BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25528797)

  • 21. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The pathogenesis and treatment of renovascular hypertension].
    Kusano E; Akai Y
    Nihon Rinsho; 1989 Sep; 47(9):2008-12. PubMed ID: 2574241
    [No Abstract]   [Full Text] [Related]  

  • 23. Is there a local renin-angiotensin system in the heart?
    Danser AH; Saris JJ; Schuijt MP; van Kats JP
    Cardiovasc Res; 1999 Nov; 44(2):252-65. PubMed ID: 10690302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
    Azizi M; Ménard J
    Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of renin and the (pro)renin receptor system.
    Guang C; Jiang B; Phillips RD; Milani F
    Blood Press; 2012 Dec; 21(6):377-85. PubMed ID: 22775989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic management of heart failure: neurohormonal agents.
    Moser DK
    Crit Care Nurs Clin North Am; 1993 Dec; 5(4):599-608. PubMed ID: 7905275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of beta-blockers and angiotensin receptor blockers/ACE inhibitors in heart failure.
    Cohn JN
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):137-9. PubMed ID: 14608516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy.
    Zaffanello M; Franchini M; Fanos V
    Pharmacotherapy; 2008 Jan; 28(1):125-30. PubMed ID: 18154482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensinogen metabolism in rat aorta: robust formation of proangiotensin-12.
    Bujak-Gizycka B; Olszanecki R; Suski M; Madek J; Stachowicz A; Korbut R
    J Physiol Pharmacol; 2010 Dec; 61(6):679-82. PubMed ID: 21224498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Renin-angiotensin-aldosterone system (RAAS) and its pharmacologic modulation].
    Giestas A; Palma I; Ramos MH
    Acta Med Port; 2010; 23(4):677-88. PubMed ID: 20687997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
    Weir MR; Rolfe M
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):531-48. PubMed ID: 20150448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics.
    Prosser HC; Forster ME; Richards AM; Pemberton CJ
    Cardiovasc Res; 2009 Apr; 82(1):40-50. PubMed ID: 19147651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue ACE inhibition and organ protection.
    Dal Palù C
    Clin Physiol Biochem; 1992; 9(3):87-8. PubMed ID: 1302162
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system.
    Sim JJ; Bhandari SK; Shi J; Kalantar-Zadeh K; Rasgon SA; Sealey JE; Laragh JH
    Am J Hypertens; 2012 Mar; 25(3):379-88. PubMed ID: 22158065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperkalemia and inhibitors of the renin-angiotensin-aldosterone system.
    Segal A
    N Engl J Med; 2004 Dec; 351(23):2450-1; author reply 2450-1. PubMed ID: 15575066
    [No Abstract]   [Full Text] [Related]  

  • 36. Prediction of chronic renal allograft dysfunction from evaluations of TGFBeta1 and the renin-angiotensin system.
    Yamada K; Hatakeyama E; Arita S; Sakamoto K; Kashiwabara H; Hamaguchi K
    Clin Exp Nephrol; 2003 Sep; 7(3):238-42. PubMed ID: 14586721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac renin is kidney-derived.
    Danser AH; Admiraal PJ; Derkx FH; Lamers JM; Verdouw PD; Saxena PR; Schalekamp MA
    J Hypertens Suppl; 1993 Dec; 11(5):S224-5. PubMed ID: 8158356
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of the renin-angiotensin system blockage on the plasma adiponectin levels and insulin sensitivity in patients with chronic kidney disease.
    Yazici M; Sonmez A; Kutlu M; Yilmaz MI
    Nephrol Dial Transplant; 2009 Aug; 24(8):2603-4; author reply 2604-5. PubMed ID: 19465556
    [No Abstract]   [Full Text] [Related]  

  • 39. Angiotensin II, tissue factor and the thrombotic paradox of hypertension.
    Celi A; Cianchetti S; Dell'Omo G; Pedrinelli R
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1723-9. PubMed ID: 21108554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual blockade of renin-angiotensin system.
    Goto A
    Kidney Int; 2003 Feb; 63(2):768; author reply 769. PubMed ID: 12631149
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.